![]() |
|
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES |
|
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: |
GW Pharmaceuticals
|
|
2 Reason for the notification (please tick the appropriate box or boxes): |
||
|
An acquisition or disposal of voting rights |
X |
|
|
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
|
|
|
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments |
|
|
|
An event changing the breakdown of voting rights |
|
|
|
Other (please specify): |
|
|
|
3. Full name of person(s) subject to the notification obligation: |
Prudential plc group of companies
|
|
4. Full name of shareholder(s) (if different from 3.): |
See schedule below
|
|
5. Date of the transaction and date on which the threshold is crossed or reached: |
25 November 2009
|
|
6. Date on which issuer notified: |
26 November 2009
|
|
7. Threshold(s) that is/are crossed or reached: |
10% to 11%
|
|
8. Notified details: |
|||||||
|
A: Voting rights attached to shares |
|||||||
|
Class/type of
|
Situation previous |
Resulting situation after the triggering transaction |
|||||
|
Number |
Number |
Number |
Number of voting |
% of voting rights |
|||
|
Direct |
Direct |
Indirect |
Direct |
Indirect |
|||
|
|
13,987,000 |
13,987,000 |
14,772,000 |
14,772,000 |
|
11.42% |
|
|
GB0030544687 |
|||||||
|
B: Qualifying Financial Instruments |
||||
|
Resulting situation after the triggering transaction |
||||
|
Type of financial |
Expiration |
Exercise/ |
Number of voting |
% of voting |
|
|
|
|
|
|
|
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments |
||||||
|
Resulting situation after the triggering transaction |
||||||
|
Type of financial |
Exercise |
Expiration |
Exercise/ |
Number of voting |
% of voting rights |
|
|
|
|
|
|
|
Nominal |
Delta |
|
|
|
|||||
|
Total (A+B+C) |
|
|
Number of voting rights |
Percentage of voting rights |
|
14,772,000 |
11.42% |
|
9. Chain of controlled undertakings through which the voting rights and/or the |
|
Prudential plc (parent Company) M&G Group Limited (wholly owned subsidiary of Prudential plc) M&G Limited (wholly owned subsidiary of M&G Group Limited) M&G Investment Management Limited (wholly owned subsidiary of M&G Limited) M&G Securities Limited (wholly owned subsidiary of M&G Limited)
|
|
Proxy Voting: |
|
|
10. Name of the proxy holder: |
N/A |
|
11. Number of voting rights proxy holder will cease to hold: |
N/A
|
|
12. Date on which proxy holder will cease to hold voting rights: |
N/A |
|
13. Additional information: |
|
|
14. Contact name: |
Dipesh Varsani / Mark Thomas M&G Investment Management Limited
|
|
15. Contact telephone number: |
020 7548 3261 / 020 7548 3266
|
Notifiable Position Report for GW PHARMACEUTICALS ORD GBP0.001
|
|
Registered Holder
|
Holding
|
%
|
|
|
|
|
|
|
|
|
Prudential plc
|
|
14,772,000
|
11.42
|
Total Notifiable Interest
|
|
|
|
|
|
|
|
|
NORTRUST NOMINEE LTD A/C MKK01
|
12,653,111
|
|
|
|
|
PRUCLT HSBC GIS NOM (UK) PPL AC
|
2,118,889
|
|
|
|
|
|
|
|
|
|
M&G Group Limited
|
|
14,772,000
|
11.42
|
|
|
|
|
|
|
|
|
|
NORTRUST NOMINEE LTD A/C MKK01
|
12,653,111
|
|
|
|
|
PRUCLT HSBC GIS NOM (UK) PPL AC
|
2,118,889
|
|
|
|
|
|
|
|
|
|
M&G Investment Management Limited
|
|
14,772,000
|
11.42
|
|
|
|
|
|
|
|
|
|
NORTRUST NOMINEE LTD A/C MKK01
|
12,653,111
|
|
|
|
|
PRUCLT HSBC GIS NOM (UK) PPL AC
|
2,118,889
|
|
|
|
|
|
|
|
|
|
M&G Limited
|
|
14,772,000
|
11.42
|
|
|
|
|
|
|
|
|
|
NORTRUST NOMINEE LTD A/C MKK01
|
12,653,111
|
|
|
|
|
PRUCLT HSBC GIS NOM (UK) PPL AC
|
2,118,889
|
|
|
|
|
|
|
|
|
|
M&G Securities Limited
|
|
12,653,111
|
9.78
|
|
|
|
|
|
|
|
|
|
NORTRUST NOMINEE LTD A/C MKK01
|
12,653,111
|
|
|
The share data supplied on this page is provided by MoneyAM Corporate Solutions and incorporates share prices, market news, indices, charts, fundamentals, heatmaps, stock screeners and investor research tools. MoneyAM Terms & Conditions.